de Boo

1 month ago | nutritionj.biomedcentral.com | de Boo |Kate Furness |J Simon |Charles H.C |Lauren Hanna |Kate Connell | +12 more

This study is a two-arm, multicentred, randomised controlled trial. Outcomes will be measured at baseline, three, and six-month follow-up time points. Figure 2 represents the study design and participant flow. The study flow chart depicts the two pathways; the intervention and usual care group. The usual care group will be screened for malnutrition at their healthcare services and will be referred to a dietitian when clinically indicated.

Jul 7, 2024 | bmccancer.biomedcentral.com | Kee Soon Fong |De Abreu Lourenco |de Boo |Yoo Young

TROG 21.07 SOCRATES-HCC is a phase II, prospective, randomised, parallel and open-label, multi-institutional superiority trial comparing SABR to other current standard of care therapies for patients with newly diagnosed early stage (BCLC 0/A), solitary ≤ 8 cm nodule HCC, ineligible for surgical resection or transplantation. The trial schema is represented in Fig. 1.